NCT00002734View on ClinicalTrials.gov

Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

April 30, 2001

Conditions
Ovarian CancerPrimary Peritoneal Cavity Cancer
Interventions
BIOLOGICAL

recombinant interferon alfa

DRUG

chemotherapy

DRUG

paclitaxel

DRUG

topotecan hydrochloride

RADIATION

lutetium Lu 177 monoclonal antibody CC49

RADIATION

yttrium Y 90 monoclonal antibody CC49

Trial Locations (1)

35294

University of Alabama Comprehensive Cancer Center, Birmingham

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002734 - Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter